Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(0.72)
# 2215
Out of 5,329 analysts
90
Total ratings
21.43%
Success rate
-0.77%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ERAS Erasca | Reiterates: Buy | 6 6 | 1.49 | 302.68% | 10 | Apr 30, 2025 | |
FHTX Foghorn Therapeutics | Reiterates: Buy | 13 13 | 4.17 | 211.75% | 1 | Apr 30, 2025 | |
STRO Sutro Biopharma | Reiterates: Neutral | 2 2 | 1.06 | 88.68% | 1 | Apr 29, 2025 | |
TARA Protara Therapeutics | Reiterates: Buy | 23 23 | 3.44 | 568.6% | 1 | Apr 28, 2025 | |
CGON CG Oncology | Reiterates: Buy | 75 75 | 27.76 | 170.17% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 2.49 | 221.29% | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 7.63 | 371.82% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 6 | 2.58 | 132.56% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 50 | 7.54 | 563.13% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 15 15 | 0.87 | 1624.14% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 25 25 | 3.65 | 584.93% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 40 50 | 32.84 | 52.25% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 1.22 | 227.87% | 11 | Nov 11, 2024 |